InMode (INMD) Cash from Financing Activities (2018 - 2026)
InMode (INMD) posted Cash from Financing Activities of -$32.4 million for Q1 2026, down 23768.61% sequentially from $137000.0 in Q4 2025, and up 67.4% YoY from -$19.4 million in Q1 2025.
InMode (INMD) Cash from Financing Activities (2018 - 2026) Analysis & Trends
InMode has reported Cash from Financing Activities for 9 years, with the latest figure at -$32.4 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 67.4% year-over-year to -$32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.0 million (up 84.57% YoY) and the FY2025 annual result came in at -$126.1 million, up 55.42% from the prior year.
- Cash from Financing Activities declined to -$32.4 million in Q1 2026 per INMD's latest filing, from $137000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $2.7 million in Q3 2023 and troughed at -$118.4 million in Q4 2024.
- A 5-year average of -$28.0 million and a median of $204000.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities surged 396.18% in 2023, then plunged 43165.09% in 2024.
- Over 5 years, Cash from Financing Activities stood at $637000.0 in 2022, then slumped by 56.83% to $275000.0 in 2023, then slumped by 43165.09% to -$118.4 million in 2024, then soared by 100.12% to $137000.0 in 2025, then slumped by 23768.61% to -$32.4 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$32.4 million, $137000.0, and $249000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -213.50 Mn |
| 10 | InMode | 913.74 Mn | 498.57 Mn | 71.52 Mn | -56.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.43 Mn |
| Mar 31, 2026 | -32.43 Mn |
| Dec 31, 2025 | 137,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | -26.98 Mn |
| Jun 30, 2025 | -26.98 Mn |
| Mar 31, 2025 | -99.47 Mn |
| Mar 31, 2025 | -99.47 Mn |
| Dec 31, 2024 | -118.43 Mn |
| Dec 31, 2024 | -118.43 Mn |
| Sep 30, 2024 | -75.99 Mn |
| Sep 30, 2024 | -75.99 Mn |
| Jun 30, 2024 | -88.59 Mn |
| Jun 30, 2024 | -88.59 Mn |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Dec 31, 2023 | 275,000.00 |